Latest Updates & News

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023
What is Leqembi prescribed for? Leqembi is prescribed to treat Alzheimer’s disease for people in the early stages of the disease. What is the name of the drug and what does it do? The U.S. Food and Drug Administration has approved Leqembi (generic name: lecanemab-irmb), pronounced “leh-kem’-bee,” for the treatment of Alzheimer's disease. ...

FDA Approves Dupixent for Children Suffering from Eosinophilic Esophagitis on January 2024
What is Dupixent prescribed for? DUPIXENT (generic name: dupilumab), pronounced DU-pix-ent is prescribed for children aged 1 year and older to treat eosinophilic esophagitis (EoE), a chronic inflammatory condition of the esophagus. EoE is caused by a buildup of eosinophils, a type of white blood cell, which leads to damage and inflammation in the esophagus. This can...

FDA Approves Amtagvi for Advanced Skin Cancer on February 16, 2024
What is Amtagvi prescribed for? Amtagvi is prescribed to treat adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. What is the name of the drug and what does it do? The newly approved drug is called Amtagvi...

FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023
What is Elevidys prescribed for? To treat Duchenne muscular dystrophy (DMD) in patients who are 4 years of age and older and have a confirmed mutation in the DMD gene. What is the name of the drug and what does it do? Elevidys (generic name: delandistrogene moxeparvovec-rokl), pronounced "el-eh-vid-iss," is a special treatment approved by the U.S....

FDA Approves BRENZAVVY for Type 2 Diabetes Management on January 20, 2023
What is BRENZAVVY prescribed for? BRENZAVVY is prescribed to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise. What is the name of the drug and what does it do? BRENZAVVY, pronounced bren-ZA-vee, (generic name: bexagliflozin) , is used to improve blood sugar control in adults with type 2 diabetes. It...

FDA Approves Xolair for Food Allergy Management on February 16, 2024
What is Xolair prescribed for? Xolair is prescribed to treat food allergy in people 1 year of age and older to reduce allergic reactions that may occur after accidentally eating one or more foods to which you are allergic. What is the name of the drug and what does it do? Xolair, pronounced ZOHL-air, (generic name: omalizumab), a medication previously...